With osteoporosis, the normal bone remodeling process is unbalanced. This imbalance leads to lower bone mass and poorer bone quality, causing a reduction in bone strength and increased risk of fracture. When patients suffer a fracture, many experience a cascade of consequences that includes loss of mobility and independence, depression and increased mortality.1
AgNovos' pioneering approach to treating patients with osteoporosis is based on experience from our founder's career in clinical practice.
The Company has conducted extensive pre-clinical and clinical research on its first treatment, OSSURE™ LOEP (Local Osteo-Enhancement Procedure). This research shows that OSSURE™ LOEP can immediately, substantially and durably increase the density and strength of treated bones.2
- Kanis JA (2007) WHO Technical Report, University of Sheffield UK: 66
- Howe et al., World Congress on Osteoporosis 2017; Hill et al., ECTS 2017; Keaveny et al., ASBMR 2017